Anthrax: developing drugs for prophylaxis of inhalational anthrax Anthrax: developing drugs for prophylaxis of inhalational anthrax

Collection: Health Policy and Services Research Series Title(s): Guidance for industry Contributor(s): United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. Center for Drug Evaluation and Research (U.S.), issuing body. Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2018 Language(s): English Format: Text Subject(s): Anthrax -- drug therapy Anthrax -- prevention & control Antibiotic Prophylaxis Clinical Trials as Topic Drug Evaluation, Preclinical -- standards Drugs, Investigational -- therapeutic use Inhalation Exposure United States United States. Department of Health and Human Services United States. Food and Drug Administration Genre(s): Guideline Technical Report Copyright: The National Library of Medicine believes this item to be in the public domain. (More information) Extent: 1 online resource (1 PDF file (13 pages)). NLM Unique ID: 101734212 (See catalog record) Permanent Link: http://resource.nlm.nih.gov/101734212